Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
Mohamad Mohty(Sorbonne Université), Enric Carreras(Josep Carreras Leukaemia Research Institute), S. Okamoto(Keio University), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Mairéad NíChonghaile(Trinity College Dublin), Fiona L. Dignan(St Thomas' Hospital), Didier Blaise(Institut Paoli-Calmettes), Fabio Ciceri(Vita-Salute San Raffaele University), Tapani Ruutu(Helsinki University Hospital), Elisabeth Wallhult(Sahlgrenska University Hospital), Peter Bader(Goethe University Frankfurt), Ali Bazarbachi(American University of Beirut), Anne Huynh(Institut universitaire du cancer de Toulouse Oncopole), Paul G. Richardson(Harvard University), Ibrahim Yakoub‐Agha(Inserm), Florent Malard(Sorbonne Université), Erik Aerts(University Hospital Zurich), Arnon Nagler(Sheba Medical Center), Michaël Abécassis(University of Arizona), Mauricette Michallet(Université Claude Bernard Lyon 1), Rafael F. Duarte(Institut Català d'Oncologia), Selim Corbacioglu(Unknown), Antonio Pagliuca, Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Tamás Masszi, Bipin N. Savani(Vanderbilt University Medical Center), J-H Dalle(Université Paris Cité), Finn Bo Petersen(Intermountain Healthcare), Takahiro Fukuda(Takarazuka City Hospital), Mutlu Arat(Istanbul Florence Nightingale Hospital), Ahmed Alaskar(King Saud bin Abdulaziz University for Health Sciences), Frédéric Baron(University of Liège)
Cited by 538
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k